Ultrasonographic comparison of gastric motility between diabetic gastroparesis patients with and without metabolic syndrome

被引:4
作者
Sogabe, Masahiro [1 ,3 ]
Kimura, Yoshitaka [1 ]
Iwaki, Hiroshi [1 ]
Okita, Yoshio [1 ]
Hibino, Shingo
Sawda, Seizo [1 ]
Okahisa, Toshiya [3 ]
Okamoto, Koichi [1 ]
Tsujigami, Koji [4 ]
Hayashi, Hiroshige [5 ]
Hukui, Yasuo [2 ,6 ]
Nakamura, Toshio [2 ,6 ]
Taniki, Toshikatsu [2 ,6 ]
Nakasono, Masahiko [3 ]
Muguruma, Naoki [3 ]
Okamura, Seisuke [3 ]
Ito, Susumu [3 ]
机构
[1] Anan Cent Hosp Med Assoc, Dept Internal Med, Tokushima 7700045, Japan
[2] Hibino Hosp, Dept Internal Med, Tokushima, Japan
[3] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Digest & Cardiovasc Med, Tokushima 770, Japan
[4] Zentsuji Natl Hosp, Natl Hosp Org, Dept Gastroenterol, Kagawa, Japan
[5] Fukuda Clin Internal Med Heart & Digest, Dept Gastroenterol, Kochi, Japan
[6] Kochi Hlth Sci Ctr, Kochi, Japan
关键词
autonomic neuropathy; diabetic gastroparesis; gastric emptying; metabolic syndrome; motility index;
D O I
10.1111/j.1440-1746.2007.05055.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: Diabetic patients with poor glycemic control or long standing disease often have impaired gastric motility. Recently, metabolic factors such as blood glucose have been reported as influencing gastric motility independently of autonomic neuropathy. Many diabetic patients have metabolic syndrome, which is strongly associated with coronary and other diseases. We investigated whether metabolic syndrome influences diabetic gastroparesis patients. Methods: We observed gastric motility ultrasonographically in diabetic gastroparesis patients including nine with and nine without metabolic syndrome. Both groups complained of upper abdominal symptoms when hospitalized to improve blood sugar control. All patients underwent upper gastrointestinal endoscopy to rule out gastric and duodenal lesions. All had autonomic neuropathy. Gastric motility was evaluated within 3 days after admission by transabdominal ultrasonography after a test meal. Results: Gastric emptying was 45.0 +/- 13.7% in patients with and 39.1 +/- 11.9% in patients without metabolic syndrome, which was not statistically significant. Frequency of gastric contractions was 8.33 +/- 2.78 per 3 min in patients with metabolic syndrome and 7.44 +/- 2.13 per 3 min in the others, which was not statistically significant. The motility index, which involves antral contractility, was 3.21 +/- 2.18 in patients with metabolic syndrome and 2.80 +/- 1.87 in the others, which was not statistically significant. Conclusions: Metabolic syndrome did not appear to contribute to delayed gastric motility in diabetic gastroparesis.
引用
收藏
页码:E17 / E22
页数:6
相关论文
共 50 条
  • [41] Gastric emptying in diabetic patients by the 13C-octanoic acid breath test: role of insulin in gastric motility
    Masahiro Matsumoto
    Rie Yoshimura
    Hirotada Akiho
    Naomi Higuchi
    Kunihisa Kobayashi
    Noriaki Matsui
    Kentaro Taki
    Hiroyuki Murao
    Haruei Ogino
    Kenji Kanayama
    Yorinobu Sumida
    Takahiro Mizutani
    Kuniomi Honda
    Shigetaka Yoshinaga
    Soichi Itaba
    Hiromi Muta
    Naohiko Harada
    Kazuhiko Nakamura
    Ryoichi Takayanagi
    Journal of Gastroenterology, 2007, 42 : 469 - 474
  • [42] Gastric emptying in diabetic patients by the 13C-octanoic acid breath test:: role of insulin in gastric motility
    Matsumoto, Masahiro
    Yoshimura, Rie
    Akiho, Hirotada
    Higuchi, Naomi
    Kobayashi, Kunihisa
    Matsui, Noriaki
    Taki, Kentaro
    Murao, Hiroyuki
    Ogino, Haruei
    Kanayama, Kenji
    Sumida, Yorinobu
    Mizutani, Takahiro
    Honda, Kuniomi
    Yoshinaga, Shigetaka
    Itaba, Soichi
    Muta, Hiromi
    Harada, Naohiko
    Nakamura, Kazuhiko
    Takayanagi, Ryoichi
    JOURNAL OF GASTROENTEROLOGY, 2007, 42 (06) : 469 - 474
  • [43] Endothelial activation and insulin resistance:: Comparison between essential hypertensives and hypertensive patients with metabolic syndrome
    Cottone, S
    Mulè, G
    Nardi, E
    Corrado, C
    Lorito, MC
    Arsena, R
    Guarneri, M
    Cusimano, P
    Riccobene, R
    Vadalà, A
    Seddio, G
    Cerasola, G
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 179A - 179A
  • [44] Relationships between Serum Adiponectin with Metabolic Syndrome and Components of Metabolic Syndrome in Non-Diabetic Koreans: ARIRANG Study
    Koh, Sang-Baek
    Yoon, Junghan
    Kim, Jang-Young
    Yoo, Byung-Su
    Lee, Seung-Hwan
    Park, Jong-Ku
    Choe, Kyung-Hoon
    YONSEI MEDICAL JOURNAL, 2011, 52 (02) : 234 - 241
  • [45] Association between Lp (a) and atherosclerosis in menopausal women without metabolic syndrome
    Gentile, Marco
    Iannuzzo, Gabriella
    Mattiello, Amalia
    Marotta, Gennaro
    Iannuzzi, Arcangelo
    Panico, Salvatore
    Rubba, Paolo
    BIOMARKERS IN MEDICINE, 2016, 10 (04) : 397 - 402
  • [46] Comparison of total and compartmental gastric emptying and antral motility between healthy men and women
    Bennink, R
    Peeters, M
    Van den Maegdenbergh, V
    Geypens, B
    Rutgeerts, P
    De Roo, M
    Mortelmans, L
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (09) : 1293 - 1299
  • [47] Target organ damage and metabolic syndrome in non diabetic hypertensive patients
    Viazzi, F
    Leoncini, G
    Ratto, E
    Vaccaro, V
    Falqui, V
    Parodi, A
    Tomolillo, C
    Deferrari, G
    Pontremoli, R
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 205A - 206A
  • [48] Relationship between metabolic syndrome and metabolic syndrome score with β-cell function by gender in non-diabetic Korean populations
    Yoon, Hyun
    Yoon, Yo Sang
    Kim, Sung Gil
    Oh, Hye Jong
    Choi, Cheol Won
    Seong, Jeong Min
    Park, Jong
    ENDOCRINE RESEARCH, 2019, 44 (03) : 71 - 80
  • [49] PREVALENCE OF THE METABOLIC SYNDROME IN DIABETIC PATIENTS LIVING IN A COASTAL REGION OF BANGLADESH
    Hossain, Mohammad Salim
    Rahaman, Md. Zahedur
    Banik, Sujan
    Sarwar, Md. Shahid
    Yokota, Kazushige
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (08): : 2633 - 2638
  • [50] Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone
    Derosa, G.
    Fogari, E.
    D'Angelo, A.
    Cicero, A. F. G.
    Salvadeo, S. A. T.
    Ragonesi, P. D.
    Ferrari, I.
    Gravina, A.
    Fassi, R.
    Fogari, R.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2007, 32 (03) : 261 - 268